The effort to understand the significance of ever-more numerous observations of fungal and bacterial components in tissues and fluids from patients with polycystic kidney disease (PKD) is the focus of this review. Could this second most common genetic disease in man be promoted or even caused by microbes or their components/ toxins found in PKD patients? Findings include fungal glucans, fungal antigens, immunoglobulin E reactive with fungal antigens, fungal DNA, bacterial endotoxin from at least three genera, and a newly discovered class of bacteria, Nanobacterium. A new species of fungus, Penicilliuni pimiteouiense, has been isolated from PKD kidney cells in vitro.
pathology driven by synergy between one or more microbes and/or microbial toxins derived from the environment. This expanded awareness of infectious disease causality has changed fundamental research and, in some cases, treatment of a growing number of chronic diseases [1] [2] [3] [4] (e.g., stomach ulcers, atherosclerosis, Alzheimer's disease, polycystic ovary disease, sarcoidosis, forms of inflammatory bowel disease, autism, schizophrenia, multiple sclerosis, cerebral palsy, systemic lupus erythematosus, Wegener's granulomatosis, diabetes mellitus,
OdaaQZc eUQfb [R ]WP NU[L[Sh
There are two views of PKD aetiology. The genocentric view holds that all ADI'KD biology can be explained by gene mutation and resultant aberrations in cell biology independent of environmental factors. Under this approach, the research focus is definition of the underlying genetic anomalies in PKD with the ultimate goal of correcting the genetic mutation responsible for PKD pathology. Alternatively, the vulnerability view posits that ADPKD represents a mutationbased vulnerability to environmental factors, such as microbes and their toxins, chemical toxins, and dietary content. Here the approach is to understand the contributions of environmental factors to PKD that will ultimatel y allow prevention of mutations to PKD genes, slow the progression of cyst growth, and preserve kidney function throughout a normal lifespan. Experimental treatments for PKD max' directly alter the behaviour of PKD cells and/or diminish the influence of microbial and dietary factors on PKD cells and tissues.
Stnttir pno}p{its in ]WD
Mutations in three separate genes yield phenotypically indistinguishable forms of ADPKD: ZUNS on chromosome 16 and ZUN9 on chromosome 4, which normally code for proteins polycystin 1 and polycstin 2, respectively, and a yet-to-be mapped gene [8, 9] . About 90 9% of ADPKD is due to mutations of the ZUNS gene. For both ADPKD types I and 2, mutations are dispersed over the entire gene suggesting that no single region of these genes is more vulnerable to mutation. Most families examined exhibit a different mutation within ZUNS and -2 genes suggesting that there is a high first-time mutation rate /ZUN 4 ZUN W 0 5 In ADPKD (heterozygote) individuals, one normal and one mutated copy of the PKD gene /ZUNDZUNW0 are present in all cells. However, kidney epithelial cells lining the larger sized cysts demonstrate a loss of heterozygosity, meaning that mutation of the remaining normal allele occurred /ZUNDZUN. 8 45 ZUNW DZUNW 0 h87jE this second mutation is proposed to be responsible for the complete loss of any remaining functional polycystin leading, by as yet unknown mechanisms, to rapid cyst formation and progression to ESRD. If true, then both ADPKD parent and offspring must each separately experience mutagenesis. This two-hit model of cystogenesis is derived from a similar model for carcinogenesis and is supported by pathological descriptions of PKD cysts as fluid-filled tumours [6, 9, 10] . The cause(s) of the first and second mutations is/are unknown. It has been proposed that the presence of three polypyrimidine tracts facilitates triple helix formation in the ZUNS gene, thereby making it highly vulnerable to mutation that results from exposure to mutagens, oxidative stress and/or errors in DNA methylation, especially during rapid duplication of DNA that occurs during wound healing [8, 9] . A vulnerability to microbe-induced stress contrasts with the concept of an intrinsic instability of the PKD genes that yields mutations independent of environmental factors.
]WD qio{ovy
Normal polycystins I and 2 are thought to associate to form a transmembrane heterodimer (2000) 11 (1) that transduces information from the extracellular environment into the cell [8, 9] . With the possible exceptions of neuronal tissue and skin, adult tissues that express polycystins also show alteration in PKD. Thus, it is inferred that ZUNW DZUNW kidney cells lacking functional polycystins ultimately cause kidney cysts due to their inability to sense their local environment, exhibit normal functioning of the cytoskeleton and regulatory pathways that are linked to it, and regulate expression of genetic information. Once cells become ZUN sy DZUNW they exhibit an enhanced rate of proliferation, an immature phenotype, dysregulation of apoptosis and anomalies in numerous other secretory pathways and formation of extracellular matrix. The ADPKD kidney exhibits interstitial inflammation, altered extracellular matrix, kidney stones, and focal clonal growth of tubular epithelial cells yielding numerous cysts of various volumes [5] [6] [7] [8] [9] . Because microbes and their toxins are known to cause mammalian cell damage and induce tissue repair processes, produce mutagens/ carcinogens, induce oxidative stress and tissue inflammation, induce apoptosis, alter DNA, affect immunomodulation, and are linked to kidney stone formation [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] , it is reasonable to examine the concept that microbes initiate and/or provoke cystogenesis.
REVIEWS IN MEDICAL MICROBIOLOGY

Str}5urtt txptri}tnts pns wu}pn inutrtions in ]WD
The first evidence that microbes contribute tc kidney cystogenesis was obtained by Werder ey al. [24] in geneticall y cystic mice. Germ-fret conditions essentiall y eliminated kidne y c ysts in these mice and increased survival to a normal lifespan; c ystic littermates raised under ambient conditions developed kidney cysts and died early in life. Gardner et al. [25, 26] found that normal rats made reversibl y cystic b y a chemical cystogen developed kidney cysts at a much slower rate under germ-free conditions than when raised in ambient conditions. Chemicalcystogenesis could be increased by injection of endotoxin 1 to the germ-free rats or moving the germ-free rats to ambient conditions. In both cases, renal interstitial inflammation was a common finding in the highly c ystic groups. Indeed, kidney inflammation is common in animal models of PKD, where reduction of tissue inflammatory reactions by drugs and diet are reported to diminish cystic lesions [9] .
In humans, multiple kidney infections are correlated with more rapid progression of PKD to ESRD [5] . Occasional findings of fungi in PKD urine have been reported [27, 28] . The greater incidence of infections and resultant greater morbidity and mortality in PKD individuals than the general population has prompted speculation that PKD may involve an as-yet uncharacterised defect v{ microbe clearance mechanisms [29] . Ir addition 80% of PKD patients are reported to have colonic anomalies, described in diverticula, which may allow enhanced entry of microbial materials from the gut (6] , as occurs in leaky gut syndrome [30] . If one or more microbes or their toxins promote cystogenesis, then such microbes must be readily available to the PKD population; that is to say, a high rate of genetic vulnerability is matched by high rate of exposure to cystogenic microbe(s) or their toxins.
PQcQOcU[Z [R YUOa[NQb MZP YUOa[NUML O[Y][ZQZcb UZ ]WP
Qnsotoxin pns uunvp{ 09 5 ;1576J5D5v{urpns
Endotoxin is regarded as the most potent and ubiquitous toxin to which man is exposed and is found in high levels in the human gastrointestinal flora. Even under normal conditions, small amounts of endotoxin are shed from bacteria in the gut and appear in the blood [31] . Early methods for the detection of endotoxins in quantities relevant to human biology required bioassa ys, such as the rabbit p yrogen test and V}}{6us Ameboc yte Lysate (LAL) assay (Fig. 1) . The classical (c)LAL assay reagents contain the components of two separate biochemical pathways that lead to gelation or colour formation, the positive result. One pathway is activated by endotoxin or purified LPS and a second pathway activated by I -* 3-/3-D-glucans (/3DG). /3DG are shed from the surface of fungi and distributed into body fluids. In the absence of positive fungal cultures and serology or fungal DNA, a finding of fiDG is commonly associated with Rxv6 52!Diigzim!wn!Limulus Hmebwk-te!S-{ite!i{{i-!inl!it{!kwmpwnent!pitpwi-{2 deep mycoses or fungaemia [321. Elevated levels parallel the development and progression of disease and can precede positive blood cultures by days or weeks. Similarly, an associated decrease in 3oG levels occurs with clinical improvement in common fungal infections, such as aspergillosis and with emerging pathogens such as Fusarium and related hyaline fungi [33] .
The cLAL assay does not distinguish between endotoxin and fungal glucans. Unfortunately, some researchers have interpreted positive LAL findings as evidence that fungi produce LPS, which they do not. More recently, reagents developed to inhibit the glucan pathway in the LAL assay (e.g., CM-curdlan) allow for a differential (d)LAL assay that does distinguish endotoxin from fungal glucans (Fig. 1) . Although the glucan pathway in the dLAL assay does not identify the genus of fungus involved, therapeutic intervention is not impeded due to the limited choice of available antifungal agents. /3DG is not detected in certain situations, such as fungal colonisation and allergic disorders [32] . In contrast to serum and urine, PKD kidney cyst fluid has a slower turnover rate and thus may be viewed as an archive of fungal components accumulated during dietary, airborne, and colonising/ infectious exposures. Measurement of these glucans in human specimens has proved useful in detecting generic fungal infections [33] .
Using the cLAL assay we found that 80% of PKD males were positive for putative endotoxin in their urine, but none of the normal healthy male volunteers showed endotoxiuria [34] . In females, the PKD patients had higher levels than did normal female volunteers, where simple introital contamination might account for the low endotoxiuria observed [3 4,351 . None of the PKD patients exhibited evidence of current infection by symptomatology or routine urine cultures. By cLAL assay Gardner et al. [36] found putative endotoxin in 12% of the human PKD kidney cysts examined without evidence of culturable bacteria. They also reported substantial inhibition and interference with the cLAL assay of cyst fluid and inflammatory cvtokines known to be induced by endotoxin (e.g., tumour necrosis factor px05
In contrast, we found that >25% of cyst fluids obtained from 12 PKD kidneys were positive for endotoxin when tested with dLAL assay modified with heating of the specimens or use of serial dilutions to minimise false-negative reactions caused by inhibitory substances, and increased incubation time to improve sensitivity [35, 37] . Kidney cyst fluids from two out of 12 ADPKD patients and one out of two autosomal recessive PKD patients contained detectable fungal glucans by this dLAL assay. Values ranged from 40-120 pg DG/ml cyst fluid; 10 pg/mI was the limit of sensitivity of this assay. Plasma /3DG levels have been reported to be less than 10 pg/mI serum in healthy volunteers. Recent reports have indicated cutoff value of 20 pg /3DG/ml proved satisfactory for sensitivity, specificity, negative predictive values and efficacy of this test. Applying this cutoff value to the PKD patients with detectable /DG yields clinically relevant results [32, 37] . Although some studies have used a higher cutoff value (e.g., 50 pg /3DG/ml), variations in ,'3DG assay sensitivity and levels found in control populations must be compared. Special care was taken to obtain the nephrectomised kidneys within 2 h of removal, the entire procedure was conducted under aseptic technique and all reagents and specimen tubes used were negative for LAL positivity (endotoxin and glucans) and fungal DNA.
Using immunological methods, we also detected endotoxin or its remnants in >75%, of human PKD cysts fluids from each of these 12 endstage PKD patients and a patient with simple cysts, a not uncommon, non-genetic condition [35] . PKD urines were positive immunologically for LPS or nanobacterial antigens [35] . Thus, endotoxin and fungal glucans are present in end-stage PKD kidney and endotoxin is present in the urines of pre-end-stage PKD patients.
Runvp{ pntivtns ou pntiuunvp{ pntiqosits
There is a clear need to improve the reliability (i.e., specificity and sensitivity) of routine clinical immunological tests for fungal components that would lead to a genus and/or species identification. Impediments to improving these tests include ignorance of unique fungal antigens, the low immunological properties of fungal antigens and cross-reactivi ties of antifungal antibodies. Urine may provide a better source of antigens than blood, as many antigens, such as polysaccharide moieties [38] , are only transiently detected in serum. Although a number of commercial immunodetection tests are available, they have yet to be proven reliable in the respective clinical settings. An exception is detection of cryptococcal capsular material by latex agglutination or enzyme immunoassay [37] . Thus, concomitant use of culture and nonculture diagnostic methods is recommended.
Using experimental immunological methods, a small number of human PKD kidney cyst fluids were assayed for fungal antigens and human antibodies reactive with fungal antigens. K{tvte{s from Fusarium, Aspergillus and Candida were found along with immunoglobulin (Ig) E, but not lgG reactive with Fusarium and Candida [39] . The biological half-life of microbespecific IgG antibodies is only several weeks [40] . Although a larger and longitudinal study is required to define the incidence and speciation of the fungal components present in PKD fluids and tissues, these limited findings are consistent with exposure of ZUN kidney to fungal components.
The gold standard for fungal diagnosis remains culture/histopathology. Fusariuni spp, as with other hyaline fungi (Penicillium, Paecilomyces spp), are under-represented in the field of serodiagnostics. The identification of hyphae of hyaline fungi by histological diagnosis has limitations due to similar morphology, even to Aspergillus, and non-pathognomonic in situ manifestations [41, 421 . Kaufman et al. [42] have demonstrated immunohistological separation and identification of these hyaline filamentous fungi using a series of polyclonal fluorescent antibodies; their very promising clinical utility, however, has not been evaluated.
Fungal DNA
A small number of PKD cyst fluids were tested for fungal DNA by PCR methods using universal fungal primers [39] . Fungal DNA was found in six out of six cyst fluids from 3 PKD patients and PKD kidney tissue samples from two patients. Use of DNA methods to identify fungal colonizations/infections is especially important because it allows speciatiorl of the organism and also overcomes the lack of specificity and sensitivity of current immunological fungal identification tests. To date, PCR methods have proven no more useful than classical serological and glucan tests for detecting fungal infections 137,43].
Culture of microbes from fluids and tissue
Over the years, we and others have attempted and largely failed to grow microbes from PKD kidney cyst fluids using routine microbiological methods. In contrast, we have encountered fungal growths when PKD kidney epithelial cells isolated from the cyst walls were propagated in cell culture [39] . Taxonomic characterisation of this fungus revealed it to be a heretofore-unrecognised species of Zt.{vpvy8vv{3 that we named Z5 çvzvte}uvp{se h;;j5
More recentl y, we have collaborated with E. 0. Kajander and N. Ciftcioglu to culture nanobacteria from human PKD c y st fluids, urine, and blood [35] . This newly-discovered, cultureresistant Gram-negative bacterium was also found by electron microscopy and/or immunological methods in PKD kidne y and liver cyst fluids. Nanobacteria were also found in aspirated cyst fluid from a patient with simple cystic kidney disease. Based on our findings of nanobacteria in PKD fluids and tissues and current knowledge of nanobacteria pathogenicity, we have proposed that nanobacteria contribute to PKD pathogenesis.
b[daOQb [R YUOa[NQb UZ ]WP
The gastrointestinal tract is the most likely source of microbial components in PKD because, first, it is the single most available pool of microbes and their components to which humans are exposed and, secondly, 80% of PKD patients exhibit anomalies of the colon. Thirdly, sentinel markers of gastrointestinal microflora (e.g., LPS of Lnpter}vqes srntvyvs0 [35] appear in kidney and liver cysts. The intact intestinal mucosa usually excludes antigen(s) of fungi from the general circulation although faecal concentrations of 1-38 Rg/g have been reported; cell walls or exopolysaccharides (MWt 20000-75000) also are not absorbed in appreciable amounts [45] . The fungal antigens found in human PKD kidney /Pusnrvuz3 Ksçertvyyus and Mn{qvqn0 are either present in the diet or colonise the human gastrointestinal tract [11, 12] . Thus, dysfunction of the intestinal mucosal barrier in PKD may be sufficient to allow chronic or more frequent episodic entry of microbes and their components with their subsequent accumulation in renal cyst fluids. As wound healing is proposed to be altered in PKD [6] , PKD gut may be more vulnerable to damage by microflora or microbial toxins in the diet.
Not to be underestimated is the potential contribution to PKD of foodborne microbial toxins, especially mycotoxins [11, 12] . The World Bank has reported that 40% of human disease is impacted by mycotoxins [46] . Although Pusnr4 yu{33 Ze{vpvyyvuz and Ksçertvyyus are found in nature, we use fumonisins of Pusnrvuz as an example of mycotoxins with a wide occurrence in the human diet. Fumonisins are known to alter the gastrointestinal tract and show kidney and liver toxicities [11, 12, 15, 47, 48] . Not discovered until about 1988, fumonisins are reported to be present in corn, grain, rice, sorghum and other agricultural products in commerce world-wide. Utilisation of agricultural products containing fumonisins is increasingly under regulatory scrutiny with import restrictions already in evidence. The need to reduce fumonisin content in food [49] has resulted in genetically engineered corn species that are resistant to insect damage, which in turn decreases the infiltration of Pusnrvur{ yielding much lower levels of fumonisins in corn kernels 1501. Even research in laboratory animals can be impacted by mycotoxins because fumonisins are reported to be present in variable levels in all batches of rodent chow tested to date [48] . Thus, experimental modification of diet may carry the unintended effect of increasing or decreasing exposure to microbial products.
O[Y][ZQZcb UZ TdYMZ ]WP cUbbdQb MZP ]WP NU[L[Sh
Three points need to be made about assumptions of microbial content and test systems. First, because survey methods for the detection of fungal components at levels relevant to chronic diseases are largely unavailable, we have taken the view that finding fungal species by DNA and/or antigen in PKD tissue and fluids is presumptive of the presence of all components of that fungus. This potentially errs on the side of inclusion, but frames issues for future research and respects the polymicrobic nature of human exposures.
Second, numerous reports describe the biology of PKD in humans and experimental animals. In contrast, the effects of microbes and their components and toxins are described in genetically normal animals or in general human populations. Thus, tests of microbial toxins in non-vulnerable populations tend to exclude or minimise potential findings of procstogenic activity. In addition, little is known of the differences in pathobiology and susceptibility to microbial toxins of kidney cells with only one mutated PKD allele compared to cells with hits to both alleles (i.e., ZUNDZUN W versus ZUN.8D ZUNW05 Third, endotoxin from Gram-negative bacteria and fungal toxins/components are known to act synergistically to cause toxicity to mammalian systems [31] . Thus, low levels of multiple toxins yield effects seen with much higher levels of a single toxin. Because all fungal infections and mycotoxicoses occur in the presence of daily exposures to endotoxin, there is an emerging view that the effects of endotoxin and fungal components on human biology are highl intertwined and perhaps inseparable in most clinical settings.
Oontriqution ou Pusnrvuz3 Ze{ vpvyvvu3{ pns Ksçertvyyus to ]WD pptwopwysio{ovy
Occasionally, kidney cysts in normal animals have been reported following exposure to toxins sr}z Pusnrvu{v3 Ze{vpvyyvuv{ and Ksçertvyyvvs [51, 521. All produce carcinogens/mutagens [11, 12] , which ma y come into play in the mutagenesis of PKD genes. In addition, toxins and other products of these fungi may alter other cellular processes and reactions that also impact functioning of PKD kidney epithelial cells with one or two mutated alleles. To illustrate these points, we have listed the effects of fumonisins as a prototypical mycotoxin with detailed anomalies reported for PKD, and the effects of endotoxin, which is known to act synergistically with fumonisin to alter a number cellular processes ( Table 1 ). The kidney is the most sensitive organ to fumonisin toxicity [48] .
Qnsotoxin pns uunvp{ (1 -;15u95D5v{urpns
Endotoxin production is the single property shared by the bacteria (nanobacteria) cultured from or tentatively identified immunologically /O5 p}yv3 Bacteroides, MTvyn{yqv{ and Lnrt}{eyyn0 in PKD kidney tissue and fluids [35] . Because Nn{}bnptervu{3 su{ ¸uv{eur{ reacts with antiMuyn{vyqvn LPS and Lnrt}{eyyn ue{seynp hyperimmune sera, and is related by 16S rDNA sequence to Lnrt}{eyyn3 findings of putative Muynzyqvn or Lnrt}{eyyn components in PKD may be due to the presence of nanobacteria. As noted in Table 1 , endotoxin is known to affect, either directly and/or in synergy with other microbial components, many of the same processes reported to be abnormal in ZUN5 The structure of LPS influences its biological activity. In turn, the structure of LPS in mammalian fluids is determined by the genus/species of the bacteria that produced it, the metabolic status of the bacteria at the time of LPS synthesis, and the subsequent degree of metabolism or degradation of LPS by mammalian cells. Much is yet to be learned of the relationship between LPS structure and ability to act synergistically with other microbial products to influence mammalian biology. LPS from O5 p}yv is reported to enhance inflammation caused by fungal glucans [53, 54] .
M{ttrption ou spwinvo{ipis qio{ovy in uu}onisin pns tnsotoxin toxirity
Sphingolipids play an essential role in the regulation of cellular activity [15] . Alteration of sphingolipid biology was one of the first effects of fumonisin to be defined [12] . Subsequent research has shown that fumonisin, its metabolites and related mycotoxins inhibit, and in some cases are metabolised by, enzymes important to sphingolipid formation [55] (Fig. 2) . Because fumonisin inhibits ceramide synthase leading to accumulation of sphinganine, a precursor to ceramide formation, the ratio of levels of free sphinganine (SA) to free sphingosirie (SO) in . HJELLE L[!HS2 Table 1 . Effects of fumonisins and endotoxin (ET) compared with anomalies of polycystic kidney disease (PKD) 
tissue and body fluids has been used as a biomarker for fumonisin-mediated toxicit y in experimental animals and man 112,151. If fumonisin plays a role in PKD biolog y , then alterations in sphingolipid levels should be observed; at this time, there is no evidence that defective polycystins impact sphingolipid biolog y . Deshmukh et al. [56] reported lower total sphingolipid content in kidneys from phenotypically cystic mice compared with their phenotypically normal (2000) 11 (1) littermates. There is a paucity of human tissue data in fumonisin intoxication, fungal infection, and in the early stages of PKD pathogenesis. Table 2 inl!Hö{tzitinöngin2 Males are known to have higher levels of kidney sphingolipids than females [58] , which is also observed in PKD individuals (Table 2) . In PKD, males exhibit a higher incidence and severity of kidney lesions [5, 6] , responsiveness to the anticystic effects of lovastatin [59] , and excretion of nanobacterial antigens than females. In normal animals, males excrete greater amounts of sphingolipids and are more sensitive to the nephrotoxic effects of fumonisin than females [48] .
REVIEWS IN MEDICAL MICROBIOLOGY
Alteration of sphingolipid biology has been proposed as important to the integrity of the gastrointestinal tract during fumonisin intoxication [15] . Supplementation with dietary sphingolipids was reported to reduce colon carcinogenesis while broader associations between cancer, sphingolipid intake, infectious disease and exposure to fumonisin and related mycotoxins were beginning to be recognised [15, 58] . Fumonisin BI is reported to alter the activity of the folate binding protein (FBP) [60] , which may result in a functional folate deficiency and subsequent vulnerabilit y to mutagenesis and cancer [61] . Because kidney FBP is responsible for recovery of >95% of filtered folate [62] and thus preservation of stores of folate, fumonisin-induced disruption of the folate recovery pathway may indirectly affect extra-renal tissues also.
As shown in Fig. 2 , endotoxin is reported to alter sphingolipid metabolism, exhibit ceramidemimetic properties, and share transport mechanisms between tissues and intracellular compartments [63] . In PKD cells, the Golgi apparatus, the intracellular site of complex sphingolipid formation and sulphation reactions, shows altered transport of sphingolipids [64] stimuli and by decreasing the absorption of endotoxin and fungal glucans from the gut by decreasing inflammation of the gastrointestinal tract. The role of diet and drugs [65] in altering the growth of colonising /infecting microbes and the production of microbial toxins is an emerging area of research not only in food safety [15] , but in both chronic and genetic diseases.
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